- Home
- CGEM vs SSYS Comparison
CGEM vs SSYS Comparison
Compare CGEM & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- SSYS
- Stock Information
- Founded
- CGEM 2016
- SSYS 1989
- Country
- CGEM United States
- SSYS United States
- Employees
- CGEM N/A
- SSYS N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- SSYS Computer peripheral equipment
- Sector
- CGEM Health Care
- SSYS Technology
- Exchange
- CGEM Nasdaq
- SSYS Nasdaq
- Market Cap
- CGEM 730.2M
- SSYS 634.6M
- IPO Year
- CGEM 2021
- SSYS 1994
- Fundamental
- Price
- CGEM $10.55
- SSYS $9.85
- Analyst Decision
- CGEM Strong Buy
- SSYS Strong Buy
- Analyst Count
- CGEM 7
- SSYS 4
- Target Price
- CGEM $31.67
- SSYS $11.50
- AVG Volume (30 Days)
- CGEM 551.6K
- SSYS 448.4K
- Earning Date
- CGEM 03-13-2025
- SSYS 03-06-2025
- Dividend Yield
- CGEM N/A
- SSYS N/A
- EPS Growth
- CGEM N/A
- SSYS N/A
- EPS
- CGEM N/A
- SSYS N/A
- Revenue
- CGEM N/A
- SSYS $578,436,000.00
- Revenue This Year
- CGEM N/A
- SSYS N/A
- Revenue Next Year
- CGEM N/A
- SSYS $3.22
- P/E Ratio
- CGEM N/A
- SSYS N/A
- Revenue Growth
- CGEM N/A
- SSYS N/A
- 52 Week Low
- CGEM $9.50
- SSYS $6.05
- 52 Week High
- CGEM $30.19
- SSYS $14.01
- Technical
- Relative Strength Index (RSI)
- CGEM 38.45
- SSYS 58.98
- Support Level
- CGEM $10.14
- SSYS $9.11
- Resistance Level
- CGEM $11.31
- SSYS $9.69
- Average True Range (ATR)
- CGEM 0.64
- SSYS 0.48
- MACD
- CGEM 0.01
- SSYS 0.07
- Stochastic Oscillator
- CGEM 30.11
- SSYS 84.66
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.